Skip to main content
. Author manuscript; available in PMC: 2012 Sep 1.
Published in final edited form as: Cancer Epidemiol Biomarkers Prev. 2011 Aug 16;20(9):1970–1978. doi: 10.1158/1055-9965.EPI-11-0139

Figure 3.

Figure 3

Comparison of mesothelin antibody and circulating antigen in ovarian cancer (●) and benign tumor (△) groups. Mesothelin and anti-mesothelin were correlated in ovarian cancer (correlation coefficient corrected for age = 0.49, p=0.02). However, not all individuals with elevated mesothelin had anti-mesothelin antibodies.